1. Home
  2. HRMY vs BORR Comparison

HRMY vs BORR Comparison

Compare HRMY & BORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.03

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Borr Drilling Limited

BORR

Borr Drilling Limited

HOLD

Current Price

$4.48

Market Cap

1.9B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
BORR
Founded
2017
2016
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
HRMY
BORR
Price
$37.03
$4.48
Analyst Decision
Buy
Hold
Analyst Count
9
2
Target Price
$44.11
$6.25
AVG Volume (30 Days)
854.1K
7.0M
Earning Date
05-07-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
7.97
N/A
EPS
0.55
N/A
Revenue
$868,453,000.00
N/A
Revenue This Year
$19.75
$5.80
Revenue Next Year
$12.88
$21.67
P/E Ratio
$67.75
$20.64
Revenue Growth
21.51
N/A
52 Week Low
$25.52
$1.85
52 Week High
$40.87
$6.66

Technical Indicators

Market Signals
Indicator
HRMY
BORR
Relative Strength Index (RSI) 68.61 43.73
Support Level $35.05 $4.02
Resistance Level $39.12 $4.55
Average True Range (ATR) 1.04 0.20
MACD 0.22 0.06
Stochastic Oscillator 93.53 70.00

Price Performance

Historical Comparison
HRMY
BORR

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About BORR Borr Drilling Limited

Borr Drilling Ltd is an offshore shallow-water drilling contractor providing services to the oil and gas industry. Its operations focus on the ownership, contracting, and operation of jack-up rigs in shallow-water areas, including the provision of related equipment and work crews to conduct oil and gas drilling and workover operations for exploration and production (E&P) customers. The company contracts its rigs on a dayrate basis to drill wells for integrated oil companies, state-owned national oil companies, and independent oil and gas companies. It operates in one reportable segment.

Share on Social Networks: